|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,830 KRW | -0.29% |
|
+1.77% | -8.05% |
| 2023 | Whan In Pharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2015 | Whanin Pharmaceutical Co. Ltd.(KOSE:A016580) added to Russell Global Index | CI |
Whan In Pharm Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 445.95 million compared to KRW 451.06 million a year ago. Net income was KRW 7,118.5 million compared to KRW 8,327.69 million a year ago.
Basic earnings per share from continuing operations was KRW 466 compared to KRW 545 a year ago. Basic earnings per share was KRW 466 compared to KRW 545 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.05% | 153M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
WHAN IN PHARM CO.,LTD. 
